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Allergies are caused by the immune reaction to
commonly harmless proteins, allergens. This
reaction is typified by immunoglobulin E (IgE)
antibodies. We report the crystal structure of
an IgE Fab fragment in complex with b-lacto-
globulin (BLG), one of the major allergens of
bovine milk. The solved structure shows how
two IgE/Fab molecules bind the dimeric BLG.
The epitope of BLG consists of six different
short fragments of the polypeptide chain, which
are located especially in the b strands, covering
a flat area on the allergen surface. All six CDR
(complementary-determining region) loops of
the IgE Fab participate in the binding of BLG.
The light chain CDR loops are responsible for
the binding of the flat b sheet region of BLG.
The IgE epitope is different from common IgG
epitopes that are normally located in the ex-
posed loop regions of antigens and observed
also in the two recently determined allergen-
IgG complexes.
INTRODUCTION
More than 25% of the human population in industrialized
countries suffers from type I hypersensitive reactions like
allergic asthma, rhinitis, food and skin allergy, and even
anaphylaxis. This type I allergy is based on the formation
of immunoglobulin E (IgE) antibodies against, in principle,
harmless proteins, allergens. The symptoms of type I
allergy are mediated when an allergen molecule binds to
two IgE antibodies bound to the high-affinity Fc3RI recep-
tors on a mast cell or basophil surface and induces cross-
linking of the IgE-Fc3RI complexes. This triggers the
degranulation of biological mediators like histamine and
lipid mediators that cause inflammatory reactions (Larche´
et al., 2006). IgE is a large molecule that consists of two
identical light and heavy chains. The 3 heavy chains of IgE
contain four constant domains (C31–C34) and one variable
domain, whereas the light chain contains one constant
domain and one variable domain (Figure 1A). RecentlyStructure 15, 1413–142solved crystal structures have revealed the structures of
heavy-chain domains C32–C34 and the binding mecha-
nism for the Fc3RI receptor. The binding of IgE requires
substantial conformational changes in C32 that lead to
the very stable IgE-Fc3RI complex (KD = 109 M), which
means that IgE can be fixed to Fc3RI even in the absence
of a bound allergen (Garman et al., 2000; Wan et al., 2002).
In the last few years, the three-dimensional structures
for a large number of different allergens have been deter-
mined. Structurally, these allergens vary considerably, and
no common structural motif that could explain the capabil-
ity of these allergens to cause synthesis of IgE antibodies
has been identified (Aalberse, 2000). However, by com-
paring plant food and pollen allergies, it has been found
that allergenicity is restricted to only a few protein families,
thus raising evidence that structural features of proteins
could also have a role in allergenicity (Jenkins et al., 2005;
Radauer and Breiteneder, 2006). Some recent experimen-
tal studies have also raised evidence that there would be
differences between IgG and IgE antibodies in the binding
of allergens. For instance, it has been found that poly-
clonal IgE antibodies against Amb a 1 and Der p 1 bind
especially strongly to allergens (KD = 10
8–1011 M) and
are directed toward only a few epitopes (Pierson-Mullany
et al., 2000). Whilst studying binding strength against pol-
len allergens Phl p 5a and Bet v 1a, it was found that IgE
antibodies bound allergens tighter (KD = 10
10–1011 M)
than IgG antibodies (KD = 10
7–108 M) (Hantusch et al.,
2005).
The essential question when studying allergenicity in-
volves the so-called B cell epitope, the IgE antibody-
binding site of an allergen that unfortunately cannot be
deduced directly from the three-dimensional structure.
To date, B cell epitopes have been sought by analyzing
fragments or peptides of an allergen that react with poly-
clonal IgE serum pools from allergic patients. In addition,
site-directed mutagenesis of allergens, use of epitope
mimics (mimotopes), and bioinformatics modeling studies
have been used (Bannon and Ogawa, 2006; Riemer et al.,
2004). However, the only rational method by which to
determine the complete epitope of any allergen involves
measuring the crystal structure of an allergen in complex
with an IgE antibody (Laver et al., 1990). So far, no struc-
tural data exist describing the structures of IgE antibod-
ies complexed with allergens, due to the fact that the1, November 2007 ª2007 Elsevier Ltd All rights reserved 1413
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Structure of the b-Lactoglobulin-IgE/Fab Complexproduction of monoclonal IgE antibodies has not been
successful through hybridoma technology.
At present, there are over 80 crystal structures of anti-
gens complexed with immunoglobulins in the Protein Data
Bank. The majority represent Fab-fragment complexes.
These structures include only one structure of an IgE anti-
body, SPE7 (Fv fragment) raised against a 2,4-dinitro-
phenyl hapten in mouse. SPE7 was found to exist in differ-
ent conformations and is able to bind different ligands,
one of which was found to be the thioredoxin of E. coli,
which is not an allergen (James et al., 2003). There are
also two published crystal structures of allergens com-
plexed with mouse IgG1 Fab fragments, the allergens in
these immunocomplexes are birch pollen allergen Bet
v 1 and bee venom Api m 2 (hyaluronidase) (Mirza et al.,
2000; Padavattan et al., 2007). In this study, we report
the first, to our knowledge, structure of an allergen com-
plexed with a Fab fragment of a recombinant IgE (D1/
Fab) antibody at 2.8 A˚ diffraction resolution. The allergen
is b-lactoglobulin (BLG, Bos d 5), which is a well-known
bovine milk allergen, and its immunogenicity has been
studied extensively (Wal, 1998). To our knowledge, the
solved structure gives first insight into the molecular inter-
actions between an IgE antibody and allergen, revealing
the structure of an IgE epitope of BLG.
RESULTS
D1/Fab Isolation, Production, and Purification
The D1 IgE antibody was isolated from a combinatorial scFv
phage display library that contains the IgE VH gene pool
combined with either the k or l VL pools. The IgE-specific
heavy chain and the light chains were amplified from the
total RNA isolated from lymphocytes of peripheral blood of
Figure 1. The Overall Structure of an Allergen-IgE Immuno-
complex
(A) A schematic view of the binding of an allergen dimer (gray) by two
IgE molecules (light chain in blue; heavy chain in green) bound to the
Fc3RI receptors on the mast cell surface. Different domains of IgE
antibodies are shown. For clarity, the second Fab fragment of the
IgEs is not shown.
(B) The solved complex structure containing the BLG dimer (gray)
complexed with two D1/Fab fragments.1414 Structure 15, 1413–1421, November 2007 ª2007 Elsevier La milk-allergic, adult patient. The IgE-specific cDNA was
amplified by using primers specific to the 3 CH2 region
and to all Ig human V regions. The IgE specificity of the
amplified cDNA pool was verified by sequencing ten individ-
ual cloned heavy-chain cDNA fragments. The scFv libraries
were constructed by combining the amplified VH-encoding
regions of the IgE-specific cDNA with the VL-encoding
regions of the k and l light chains. TheD1 IgE scFv fragment
was selected from the library by using biotinylated BLG
immobilized on streptavidin wells. The isolated D1 IgE
scFvwas converted to a Fab fragment by cloning the human
Ck and the CH1 region of IgG1 to its VL and VH regions,
respectively. The Fd chain was designed to contain the
IgG1 constant region because our previous expression ex-
periments have shown that recombinant IgE Fab fragments
are produced in lower amounts in E. coli (Laukkanen et al.,
2003). The D1/Fab fragment was produced by high-cell
density fermentation of E. coli strain RV308 (ATCC 31608)
and was purified by metal affinity chromatography, as de-
scribed by Nevanen et al. (2001). The equilibrium dissocia-
tion constant (KD = 1.4 3 10
9 M) and kinetic parameters
(kon = 1.43 10
6, koff = 1.543 10
3) determined by BIAcore
indicate strong binding of D1/Fab to BLG, which is typical
of IgE antibodies. Amore detaileddescription of the isolation
and characterization of the D1/Fab will be published else-
where (S.J. et al., unpublished data).
Overall Structure of the Immunocomplex
Crystals were obtained at pH 5.5, in which the BLG protein
exists predominantly in the dimeric form (Sakurai and
Goto, 2002); consequently, the solved structure shows two
D1/Fab molecules (chains L, H and chains M, I) bound to
the dimeric BLG (chains A, B) (Figure 1B). The structure
shows a 2-fold symmetry axis between twoBLGmonomers.
The location of the axis is similar to that of the native dimeric
BLG, and6% (530 A˚2) of themonomer surface is buried on
thedimer interface. The conformationofBLG in the immuno-
complex is also similar to the structure of native BLG, except
for a slight difference in the position of the C terminus
(Brownlow et al., 1997). An elongated electron density was
found in both lipid-binding cavities of BLG monomers; this
density was interpreted to be that of n-dodecyl-b-D-malto-
side,which is usedasadetergent in crystallization. Themalt-
oside part of the detergent is outside the cavity, but far away
from the Fab fragment; therefore, the binding of ligands
would probably not affect antibody binding. The overall
structures of D1/Fab fragments are clearly bent. The calcu-
lated elbow angles were 141 and 150 for Fab fragments
H/L and I/M, respectively. These values are typical of Fab
fragments in which the L chain is of type k. In the antibodies
that have type l L chains, elbow angles are usually larger
(>195) (Stanfield et al., 2006).
IgE Epitope of BLG
The IgE-binding site of BLG is explicitly located in one
monomer and does not extend to the second monomer
or to the dimer interface (Figure 2A). In total, 27 residues
of BLG (17% in total) are at least partially buried in the
complex structure; the buried area in BLG is 890 A˚2td All rights reserved
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Structure of the b-Lactoglobulin-IgE/Fab Complex(10% of the monomer surface), which is large but still sim-
ilar to that of known antigen-IgG complexes (650–1050 A˚2)
(Davies and Cohen, 1996). D1/Fab packs against a flat
surface of BLG. The B cell epitope for D1/Fab consists
of six different segments of the polypeptide chain (Figures
2B and 3). Strikingly, the bulk of the epitope consists of
the residues of the secondary structure elements (74%).
The solvent-accessible surface of BLG has about half
of the residues from the secondary structure elements
(57%) and about half from the loop regions (43%). A large
part of the epitope is formed by the first four b strands,
A (epitope segment 1; W19-Y20), B (segment 2; V43-K47),
C (segment 3; L57-Q59), and D (segment 4; C66-Q68). In
addition, the loop between strand H and the following
helix (segment 5; P126-E127) and the short C-terminal a
helix (segment 6; T154-E157) form part of the epitope (Fig-
ure 2B). There are 15 amino acid residues in BLG (9%
in total) that are in contact with D1/Fab. These residues
make 2 salt bridges and 13 hydrogen bonds with the
antibody.
CDR Loops of D1/Fab
The overall structure of the two variable domains of D1/
Fab is similar to that of the known IgG structures. All three
CDR loops from the light chain and CDR loops H1 and H2
from the heavy chain belong to the common canonical
classes of immunoglobulins (Al-Lazikani et al., 1997).
However, CDR-H3 is an unusually long loop. It has 17 res-
idues and a bulged conformation in the torso region
(Morea et al., 1998). The head region of CDR-H3 packs
against all other CDR loops, extensively filling the groove
between the two variable domains (Figure 4). This groove
is usually the central part of the antigen-binding site in IgG
antibodies. As it is common in immunocomplexes, the
buried area is higher in the H chain (550 A˚2) than in the L
chain (385 A˚2). In total, 14 residues of D1/Fab make con-
tact with BLG, and only 2 of them (Y49 and Y91 from the
light chain) are aromatic, which is unusual (Davies and Co-
hen, 1996). Three light-chain loops contain 7 residues that
Figure 2. The D1/Fab IgE Epitope of BLG
(A) Location of two monovalent epitopes in the BLG dimer.
(B) The IgE-binding epitope of BLG. The residues making contacts are
shown in red, and the residues that are buried upon binding of the IgE
are shown in orange. The different segments of the epitope are num-
bered 1–6.Structure 15, 1413–142are all in contact with the b sheet of BLG (segments 2, 3,
and 4). CDR-L1 and CDR-L2 are both in contact with 3
residues of BLG: S30, S31, and R32 and Y49, A50, and
S52, respectively. CDR-L3makesonly onehydrogenbond
with BLG through the phenolic hydroxyl group of Y91.
Three heavy-chain CDRs also make seven contacts with
the BLG. H31 of CDR-H1 binds to the loop on the edge
of the epitope (segment 5), and CDR-H2 binds to the
C-terminal helix (segment 6) via residues S52 and S54.
In the middle of the D1/Fab-binding area of BLG, there
is a small depression between the C-terminal a helix and
b strands A and B. CDR-H3 utilizes this cavity by placing
Arg101 between Y20 from strand A and E40 from strand
B (segments 1, 2, and 5). V102 of the CDR-H3 loop is also
important for binding to Y20 from epitope segment 1 and
to P126 from epitope segment 5 (Figure 4).
The comparison of 52 germline VH sequences with the
VH region of D1/Fab revealed that the VH3-23 is highly
identical (83%) to D1/Fab. This germline sequence has
two identical interacting residues with the D1 sequence
in the CDR-H2 loop (S52 and S54). H31 from the CDR-
H1 loop of D1 was replaced by a smaller side chain, serine
in VH3-23. This suggests that S31H mutation could repre-
sent a somatic mutation that improves the binding affinity
and selectivity of D1/Fab.
DISCUSSION
D1/Fab and Homology in the IgE Light Chains
D1/Fab is a recombinant human antibody with the VH
region from the IgE Fd-specific cDNA combined in vitro
to the Vk region, and, thus, it is not necessarily a pairing
that occurred naturally in the patient in response to the
BLG allergen. However, we found that the CDR loops of
the D1 light chain are highly homologous with CDR loops
of a few available IgE antibodies raised against different
allergens, which indicates that the selected VH/VL combi-
nation might present an authentic pairing of an IgE anti-
body. Very few amino acid sequences of IgE antibodies
are available today. Comparison of the sequences of the
heavy chains is typical for antibodies, and, as one might
expect, the largest differences can be found in the CDR-
H3 regions. However, some sequences of the IgE light
chains showed very high identity (85%–90%) with the
D1 light chain. In particular, CDR-L1 and CDR-L2 loops
were quite conserved. The light chain of D1 shares high
homology with light chains of IgEs, which bind allergens
Phl p 1, Phl p 2, Phl p 5, and Hev b 6, which all belong
to structurally different protein families (Flicker et al., 2002,
2006; Laukkanen et al., 2003; Steinberger et al., 1996).
This suggests that a flat surface of a b sheet or a similar
flat patch could be characteristic for other IgE epitope
structures as well. However, in the absence of structural
data for these allergen-IgE immunocomplexes, it is diffi-
cult to estimate the significance of the high L chain iden-
tity. However, at least in the case of the D1 antibody,
CDR-L loops are essential for the binding of the b sheet
surface of BLG allergen (Figure 4).1, November 2007 ª2007 Elsevier Ltd All rights reserved 1415
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Structure of the b-Lactoglobulin-IgE/Fab ComplexFigure 3. The Amino Acid Sequence Comparison of Lipocalin Allergens
The amino acid residues of the epitope of BLG (direct contacts with D1/Fab) are shown in red. The other residues buried in the binding of D1/Fab are
shown in orange. a helices are marked with ‘‘===’’; b strands are marked with ‘‘—>.’’Epitope Mapping
The epitopes of BLG have been characterized in many
studies during the last two decades. In a recent study, Ja¨r-
vinen et al. (2001) used 77 overlapping decapeptides to
define 6 IgG and 7 IgE epitopes of BLG against polyclonal
human sera. The identified IgE epitope peptides cover
62% of the polypeptide chain of BLG. The two strongest
epitopeswere located in a loop (K75-D85) and in theahelix
(E127-P144), which are not found in the epitope structure
of BLG-D1/Fab. Three weaker epitope peptides (L31-P48,
K47-K60, and L57-I78) extend over segments 2, 3, and 4.
The epitope L31-P48 was the only peptide that was not
recognized by IgG antibodies (Ja¨rvinen et al., 2001). In an-
other study, two methods were used: a PEPSCAN assay
with 151 overlapping dodecapeptides, which was used
to investigate the binding of rabbit polyclonal antisera to
BLG; and the mimotypes identified by peptide phage dis-
play, which were used to study the binding to anti-BLG
IgG. By these methods, four continuous epitopes, which
are all located in loops and are not found in the epitope
of the BLG-D1/Fab-immunocomplex structure, were1416 Structure 15, 1413–1421, November 2007 ª2007 Elsevieidentified (Williams et al., 1998). There is limited correlation
between the BLG-D1/Fab epitope obtained from the
immunocomplex structure of BLG-D1/Fab and the results
from the peptide scanning. The peptide scanning is based
on the use of polyclonal IgE antibodies to recognize linear
peptides that do not necessarily exist in the same con-
formation as in the native allergen.
Clement et al. (2002) have characterized the IgG epitope
mapof BLGby using 52monoclonal antibodies in a compet-
ive immunoassay. The 12 identified antigenic regions were
further characterized by site-directedmutagenesis. Accord-
ing to their study, themost antigenic regions were located in
the a helix and in the external loops. The highest decrease in
affinity of antibodies toward mutated BLG (over 1000-fold)
was found for the mutants E127A, E127Q, D130N, and
E134Q; E127 is located in segment 5 on the outer edge of
the D1 epitope. However, according to the BLG-D1/Fab
structure, the effect of the substitutions E127A and E127Q
on the binding would only be small. On the other hand, ami-
nor antigenic area was found to be located in segment 2 in
the b strand (mutants E44A, E44G-E45G) (Clement et al.,r Ltd All rights reserved
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Structure of the b-Lactoglobulin-IgE/Fab Complex2002). Thus, the epitope of the BLG-D1/Fab is not located in
the most antigenic area accessible for IgG antibodies, but it
may have overlapping areas with minor antigenic sites.
There are several computer programs for the prediction
of B cell epitopes. Using a number of amino acid propen-
sity scales, most of them are based on protein sequences
and the use of hydrophilic properties, flexibility, b turns,
and surface accessibility. In the case of the BLG-D1/Fab
structure, thesemethods fail to predict the correct epitope
because the most important epitope region is located in
the b sheet structure. Recently, a new program, Disco-
Tope, that uses the data from experimentally determined
antigen-antibody structures to predict discontinuous B
cell epitopes, has been developed (Andersen et al., 2006).
This program was used in the context of the three-dimen-
sional structure of BLG. The analysis resulted in 13 puta-
tive B cell epitope residues that were located in the loops
and in the two C-terminal a helices. Only one of them was
the same as in the BLG-D1/Fab structure, namely, T154 in
Figure 4. The Binding of D1/Fab to the BLG Epitope
(A) The residues making contacts between the CDR loops of the D1/
Fab and BLG are shown. Arginine101 from the CDR-H3 loop is the
key residue for binding. It extends to the small cavity between
W19-Y20 from b strand A and E44 from b strand B of BLG.
(B) The surface of the D1/Fab fragment. The CDR loop regions are
colored with different shades to illustrate their participation in the bind-
ing of the BLG allergen. The light chain is shown in blue, and the heavy
chain is shown in green.Structure 15, 1413–142the C-terminal a helix. Because DiscoTope suggests epi-
topes located in the protruding areas, it does not identify
the epitope located in the b sheet.
Crossreactivity
BLGbelongs to the lipocalin protein family, which contains
several known animal allergens from cow, horse, dog, rat,
mouse, and cockroach. The overall three-dimensional
structures within the family are very similar (Rouvinen
et al., 1999). However, a sequence comparison reveals
that the interacting residues are not conserved, suggest-
ing that these allergens are not crossreactive with D1/Fab
(Figure 3). This is in accordance with the low sequence
identity (8%–25%) between BLG and the above-men-
tioned lipocalin allergens. However, b-lactoglobulin from
reindeer milk has recently been reported to be partially
crossreactive with BLG-specific IgE sera, and the ob-
served crossreactivity is in accordance with the structure
of BLG-IgE/Fab. There are only 9 amino acid residues that
are different between these two proteins (94% identity)
(Oksanen et al., 2006). Structure comparison showed that
E65 of BLG, which is located just before epitope segment
4, is replaced by lysine in the reindeer b-lactoglobulin. This
substitutionwould bring the side chain of K65 very close to
His92 from the CDR-L3 loop in the complex, which might
decrease the binding to D1. The last two residues, H161
and I162, are also different in the reindeer b-lactoglobulin,
causing changes in the position of the small C-terminal
a helix and, thus, in segment 6.
The Dimeric Nature of an Allergen
The dissociation constant for the BLG dimer formation is
low (KD = 5.0 3 10
6 M); however, BLG exists predomi-
nantly as a dimer at neutral pH (Sakurai and Goto, 2002).
From the crystal structure of BLG-D1/Fab (Figure 1B),
we can see that Fab fragments are located in positions
such that the dimeric BLG is able to crosslink two IgE-
Fc3RI receptor complexes.
Allergens require at least two IgE epitopes for crosslink-
ing. This presumes the development of at least two differ-
ent IgE antibodies for monomeric allergens. In addition,
the crosslinking requires that two IgEs are able to bind
simultaneously to the epitopes of the antigen. If the aller-
gen is able to form dimers, oligomers, or even aggregates,
the development of only one IgE may be sufficient for
crosslinking. Therefore, the capability of an allergen to
form dimers, such as in the case of BLG, could increase
the potency of proteins to operate as allergens. BLG is
a member of the lipocalin protein family, which contains
many animal allergens. Many allergens of the lipocalin
protein family, such as Aca s 13, Can f 1, Can f 2, Cav p
2, Equ c 1, Mus m 1 and Rat n 1, are able to form dimers
(Eriksson et al., 1999; Kamata et al., 2007; Fahlbusch et al.,
2003; Lascombe et al., 2000; Bo¨cskei et al., 1992). In fact,
dimeric or tetrameric allergens can also be found in many
other allergen classes. So far, the significance of allergen
dimerization for crosslinking has been studied very little.
Scho¨ll et al. (2005) have recently shown that the dimeric,1, November 2007 ª2007 Elsevier Ltd All rights reserved 1417
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Structure of the b-Lactoglobulin-IgE/Fab ComplexFigure 5. Binding Forms of Ig Antibodies
(A) BLG-IgE/Fab.
(B) Thioredoxin-IgE/Fv (1OAZ).
(C) Bet v 1-IgG/Fab (1FSK).
(D) Api m 2-IgG/Fab (2J88).
(E) CDR23-IgG/Fab (1YJD).
(F) Lysozyme-IgG/Fab (3HFM).
Proteins are represented as ribbon models. Allergens are gray, and antibody chains are green. The interaction surface between the antigen and
antibody has been calculated with the program AMIRA. The surface is in orange on the side of the allergen/antigen and in blue on the side of the
antibody.not the monomeric, form of the major birch pollen allergen
Bet v 1 was able to crosslink IgE antibodies on mast cells.
Comparison of Immunocomplexes
When comparing the BLG-D1/Fab structure to those of
other immunocomplexes, it must be kept in mind that the
analysis is based on only one example of an allergen-IgE
complex. The most striking feature of the structure of the
BLG-D1/Fab immunocomplex is the light-chain interaction
with the flat surface of theBLG formedmainly by a b sheet.
This kind of epitope structure is very unusual among
the known crystal structures of immunocompolexes. We
found 82 different protein-antibody immunocomplexes in
the Protein Data Bank that almost exclusively represent
antigen-IgG complexes. We have looked at the structural
elements in epitopes (a helices, b strands, and loops) and
the shapes of epitopes (convex, planar, and concave) (Fig-
ure5).Half of theepitopeswere formedby loopsalone, and
the other half contained both loops and secondary struc-
ture elements. The majority of the epitopes (68%) were
located in the convex or protruding areas of antigens.
The published immunocomplex structures include only
two IgG1 Fab fragments complexed with allergens, birch1418 Structure 15, 1413–1421, November 2007 ª2007 Elsevipollen allergen (Bet v 1; 1FSK), and bee venom hyaluron-
idase (Api m 2; 2J88) (Mirza et al., 2000; Padavattan et al.,
2007). Both of these IgG antibodies competed for allergen
binding with IgE sera, suggesting that the IgG and IgE
epitopes at least partially overlap. In both cases, antibody
is bound to the protruding region of the allergen. In Bet v 1,
the epitope is formedmainly by the b hairpin, and, in Api m
2, the epitope is formed by the helix-turn-helix motif. Thus,
the epitopes are very different than in the BLG-D1/Fab
complex (Figures 5A, 5C, and 5D). On the other hand,
the protruding shapes of these two IgG1 epitopes are sim-
ilar to those commonly observed in the antigen-IgG immu-
nocomplexes that have been predicted to be the most
antigenic (Thornton et al., 1986). Lysozyme, complexed
with the HYHEL-10 IgG antibody (3HFM), partially shows
binding to a smaller flat face, but the overall shape of the
epitope is convex (Figure 5F) (Padlan et al., 1989).
Concave epitopes represent the second largest group
of immunocomplexes (23%). Typical examples are neu-
tralizing antibodies of HIV or single-domain antibodies of
dromedaries, lamas, or sharks. In these antibodies, the
exposedCDR-H3 loops bind larger clefts or cavities on the
antigen surfaces (Desmyter et al., 1996; Saphire et al.,er Ltd All rights reserved
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Structure of the b-Lactoglobulin-IgE/Fab Complex2001; Stanfield et al., 2004; De Genst et al., 2006). A sim-
ilar type of binding can be seen only in one previously de-
termined IgE immunocomplex, in which the CDR-H3 loop
binds to the concave area of thioredoxin formed by three
loops (Figure 5B). The crystal structure of a monomeric,
soluble form of CD28 in complex with the Fab fragment
of a mitogenic antibody (1YJD), which shows the only ex-
ample in which the epitope is partly formed by a flat face of
a b sheet, also has a concave epitope shape. (Figure 5E)
(Evans et al., 2005).
A smaller group of immunocomplexes (9%) represent
the antibody binding to the flat or to the quite flat area.
These seven structures contain four structures in which
the epitope is predominantly formed by loops (1G9M,
1DVF, 1OSP, 1YNT) and three structures in which the epi-
tope is formed by helices and loops (1W72, 1AR1, 1EZV).
Among the known immunocomplex structures, there is no
example of a flat epitope formed by b structures, which is
seen in the BLG-D1/Fab complex.
Nature of the IgE Epitope
Some experimental evidence exists that suggests that
allergen-specific IgE may be directed to epitopes different
from those recognized by IgG. In addition, it has been
demonstrated that allergenicity is limited to a small num-
ber of protein families, which indicates that structural
features could contribute to the allergenicity. However,
structurally, allergens present very different folds, which
make direct comparison between allergen structure and
putative IgE epitopes difficult. Another point of viewcomes
from the findings that some allergens are weak immuno-
gens for the development of IgG antibodies (Larche´ et al.,
2006; Saarelainen et al., 2002), and that IgG antibodies
have a smaller affinity with allergens. This suggests that
allergens have less preferable binding sites for IgG anti-
bodies. It is known that IgE is made in response to para-
sitic worms (helminths) and arthropods (Yazdanbakhsh
et al., 2002). Thus, it is possible that an IgE antibody re-
sponse is developed to detect unusual structural features
of molecules from these parasites that are less attainable
for IgG antibodies.
To our knowledge, the BLG-D1/Fab structure is the first
determined allergen-IgE structure. It reveals the binding of
the IgE antibody to the epitope, which is planar and con-
siss mainly of a b sheet structure. It is therefore different
from typical epitopes for IgG antibodies, which are located
in loops that protrude from the surface of the antigen.
However, it is clear that we need more allergen-IgE com-
plex structures to prove that there is a difference in the
epitope preference between IgE and IgG.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection
Microcrystals (about 703 50 3 50 mm) of BLG-D1/Fab were obtained
with a vapor-diffusion method by mixing 2 ml D1/Fab solution (concen-
tration 1.4 mg/ml in 20 mM phosphate buffer [pH 7.0]), 1 ml BLG solu-
tion (2 mg/ml in pure water), 0.5 ml n-dodecyl-b-D-maltoside solution,
and 2.5 ml reservoir solution (14% [w/v] polyethylene glycol 3350, 0.1
MBTP [1,3-bis(tris[hydroxymethyl]methylamino)propane-hydrochloricStructure 15, 1413–142acid] buffer [pH 5.5]). The diffraction data set was collected from a sin-
gle crystal at beamline ID29 in ESRF (wavelength 1.000 A˚) at 100 K. The
crystal belonged to the space group P212121 with unit cell dimensions
of a = 67.0, b = 100.6, c = 168.1 A˚. The data set was collected at 2.8 A˚
resolution (Table 1). A more detailed description of crystallization will
be published elsewhere (M.N. et al., unpublished data).
Structure Determination
The structure was solved with the molecular replacement method by
using theMolrep program implemented in the CCP4 program package
(CCP4, 1994). A BLG monomer (PDB code: 1B8E) and Fab fragment
of the IgG antibody against GP41 of HIV virus (1DFB) (identity 92%
for light chain, and 79% for heavy chain) were used as search models.
The final structure contained one dimer of BLG complexed with two
Fab fragments in an asymmetric unit. Model building and refinement
were done with the programs O and CNS, respectively (Jones et al.,
1991; Bru¨nger et al., 1998). Because of a low number of unique reflec-
tions, restraints were used for atomic coordinates and individual B
factors to keep both D1/Fab fragments and BLG monomers similar
during the whole refinement. BLG exists in two isoforms, and the
electron density suggested that we have glycine at position 64 and
alanine at position 118. No water molecules were added, but the
long electron density in the lipid-binding pocket of BLG was modeled
as an n-dodecyl-b-D-maltoside. The final structure has an R value of
24.5% and an Rfree value of 29.9%. In the Ramachandran plot, 83.5%
of the residues were in the most favored regions, and 0.6% of the
Table 1. Data Collection and Refinement Statistics
Data Collection
Space group P212121
Cell dimensions
a, b, c (A˚) 67.0, 100.6, 168.1
Resolution 2.8 (2.80–2.90)a
Rsym 0.159 (0.552)
I/sI 13.1 (3.5)
Completeness (%) 99.8 (100.0)
Redundancy 7.2 (7.4)
Refinement
Resolution 2.80–20.00
Number of reflections 27,196/1,431 (test)
Rwork/Rfree 0.246/0.291
Number of atoms 9,136
Protein 9,066
Detergent 70
Water 0
Average B factors 27.4
Protein 27.4
Detergent 59.0
Water n.a.
Rms deviations
Bond lengths (A˚) 0.009
Bond angles () 1.2
a The highest-resolution shell is shown in parentheses.1, November 2007 ª2007 Elsevier Ltd All rights reserved 1419
Structure
Structure of the b-Lactoglobulin-IgE/Fab Complexresidues were in the disallowed regions (Table 1). Buried surface area
calculations were conducted with the Areaimol program (CCP4, 1994).
All figures were generated with PyMol (DeLano, 2002).
Supplemental Data
Supplemental Data include one figure showing the representative
electron density map available at http://www.structure.org/cgi/
content/full/15/11/1413/DC1/.
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